detoxified shigella flexneri 2a artificial invasin complex
Vaccineexperimental
Clinical trial activity
2 trials · 8 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Apr 23, 2019 (NCT03869333)
Timeline
2010s
- Jan 1, 2019
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- Shigella flexneriImmunity, active
Shigella flexneri immunity, active
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT05961059 | Phase 1 | Nov 30, 2023 | Centre for Infectious Disease Research in Zambia (CIDRZ), European and Developing Countries Clinical Trials Partnership (EDCTP), European Vaccine Initiative (EVI), Heidelberg, Germany, Leiden University, PATH, United States Army, University of Gothenburg |
| NCT03869333 | Phase 1 | Apr 23, 2019 | PATH, United States Navy |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (8)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| PATH | Academic/Hospital | 2 | 1 | 1 | 2019 |
| Centre for Infectious Disease Research in Zambia (CIDRZ) | Academic/Hospital | 1 | 0 | 1 | 2023 |
| European and Developing Countries Clinical Trials Partnership (EDCTP) | Academic/Hospital | 1 | 0 | 1 | 2023 |
| European Vaccine Initiative (EVI), Heidelberg, Germany | Government | 1 | 0 | 1 | 2023 |
| Leiden University | Academic/Hospital | 1 | 1 | 1 | 2023 |
| United States Army | Government | 1 | 0 | 1 | 2023 |
| United States Navy | Government | 1 | 0 | 1 | 2019 |
| University of Gothenburg | Academic/Hospital | 1 | 0 | 1 | 2023 |
8 organizations
Page 1 / 1